Wolfgang Miesbach: Why B-Cell Depletion Is Not Always Enough in Immune Thrombocytopenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by John Semple, published in JTH, adding:
”How platelets are lost — autoantibodies, cytotoxic CD8⁺ T cells (granzyme/perforin), complement, Fc-independent desialylation via the Ashwell-Morell receptor and impaired megakaryopoiesis (explaining normal TPO levels – TPO-RA success).
- When tolerance breaks down — Th1/Th17 skewing, Treg defects, dysfunctional Bregs and MDSCs – systemic immunoregulatory failure, conceptually akin to SLE.
- Why it starts — genetics, infections (H. pylori), microbiome and environment.
- What this means — durable remission may require restoring immune balance, not just suppressing effector pathways. B-cell depletion alone may fall short where T-cell cytotoxicity dominates.
A clear move toward precision care, with biomarkers, complement signatures and glycosylation patterns guiding therapy.
In Journal of Thrombosis and Haemostasis (JTH), John Semple reflects on the new review by Kerry Hillier, et al. — reframing immune thrombocytopenia (ITP) from a purely antibody-mediated cytopenia into a multifaceted syndrome of immune dysregulation.”
Title: Understanding immune thrombocytopenia pathophysiology has come a long way
Authors: John Semple

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk